The Helsinn Group has become one of the world’s leading supportive cancer care companies, with a comprehensive portfolio of medicines and therapies helping to improve the lives of patients in 90 countries worldwide.

We are committed to developing new treatments, with a growing pipeline of future cancer therapies, including first-in-class therapies that will fulfil more medical needs in the treatment of cancer.

We work with host of longstanding  partners worldwide who share our vision and values, with a unique business model, combining integrated early- and late-stage licensing programmes to complement our own product development.

Damastown Rd, Damastown, Dublin 15, Ireland DB
Tel: +353 1 822 5404

PharmTech News Articles

FDA issued a warning letter to Cixi Zhixin Bird Clean-Care Product Co., Ltd for violations of cGMP for finished pharmaceuticals.

The company announced an investment in a new facility in Dundalk, County Louth, Ireland.

Pharmco Laboratories received an FDA warning letter for significant violations of CGMP for finished drugs and APIs at its Florida, US facility as well as misbranding of over-the-counter (OTC) acne and sunscreen drug products.

Novo Nordisk entered a research collaboration with the University of Oxford focused on Type 2 diabetes.